Mass Spectrometry and Identity Confirmation

Identity and Purity Are Separate Questions

HPLC purity testing measures how much of the material in a vial elutes as a single peak relative to everything else present, expressed as a percentage of total peak area. It is a measure of homogeneity, not a measure of what that peak actually is. A sample can show a very clean, very high single peak on HPLC and still be the wrong compound entirely, if what was run through the column was never the peptide claimed on the label to begin with.

Identity testing is the separate question of confirming what the material actually is, independent of how clean it looks. Mass spectrometry is the primary tool for that confirmation, because it measures a physical property, mass, that is specific to a molecule's structure, rather than a chromatographic behavior that a similarly sized molecule could mimic.

A COA that reports purity alone, with no identity confirmation, has answered only one of the two questions a buyer actually needs answered.

How Mass Spectrometry Determines Molecular Weight

Mass spectrometry works by converting molecules in a sample into gas-phase ions, then separating those ions by their mass-to-charge ratio, written m/z, and measuring how many ions arrive at each ratio. The output is a spectrum, a plot of signal intensity against m/z. For a peptide, the ionization step and the mass analyzer together produce a set of peaks that can be converted back into a molecular weight for the intact peptide.

The core value of the technique is specificity. Every peptide has a defined amino acid sequence, and that sequence corresponds to an exact, calculable molecular weight. If the ionized sample produces a mass matching what that sequence predicts, within instrument tolerance, that is direct physical evidence the correct compound is present.

ESI-MS and MALDI-TOF: The Two Common Methods

Two ionization approaches dominate peptide identity testing, and they differ in how the sample is turned into ions.

Both are legitimate and widely used. ESI tends to produce a series of multiply-charged ions from a single molecule, described further below, while MALDI-TOF more often produces a simpler spectrum dominated by singly-charged ions. Neither method is inherently more correct; the choice usually reflects what instrumentation a lab has and whether the identity check is run inline with a purity run or separately.

Observed Mass vs Theoretical Mass

Every peptide identity result is a comparison between two numbers: the observed mass, measured directly by the instrument, and the theoretical, or calculated, mass, derived mathematically from the peptide's known amino acid sequence.

A usable identity confirmation states both numbers explicitly, along with the difference between them. A well-run confirmation on a peptide in the size range typical of most research compounds will usually show the observed mass within a fraction of a percent of the theoretical value, close enough that the difference is attributable to normal instrument calibration variance rather than to a structural discrepancy. The acceptable deviation window depends on the instrument and the mass range involved, and a lab report should state what tolerance it is applying rather than leaving the reader to guess whether the deviation shown is normal or a flag.

A COA that reports only an observed mass, with no stated theoretical mass to compare it against, has not actually demonstrated a match. There is nothing to check it against.

Monoisotopic Mass vs Average Mass

A molecule's calculated mass can be expressed two different ways, and confusing them can make an accurate result look like a mismatch.

• Monoisotopic mass is calculated using the mass of the single most common isotope of each element in the molecule, for example carbon-12 rather than carbon-13. This is the number typically reported by high-resolution mass spectrometers.
• Average mass is calculated using the standard atomic weight of each element, which is itself an average across that element's naturally occurring isotope mixture. This number is what most molecular weight calculators show by default and is typically a small amount higher than the monoisotopic figure for larger molecules.

For a small peptide, the gap between the two is modest, but for a peptide with many carbon and sulfur atoms it can be several mass units, easily large enough to look like a discrepancy to someone comparing the wrong pair of numbers. Before flagging a mismatch, confirm the observed mass is being compared against the correctly matched theoretical figure, monoisotopic against monoisotopic, average against average.

Reading Charge States

In ESI-MS particularly, a peptide rarely ionizes as a single, singly-charged ion. Instead it typically picks up multiple protons, producing a series of peaks at different m/z values, each corresponding to the same molecule carrying a different number of charges, written as [M+H]+, [M+2H]2+, [M+3H]3+, and so on.

Because m/z is mass divided by charge, each of these peaks appears at a different position on the spectrum even though they all come from the same intact molecule. Software reconstructs, or deconvolutes, this charge-state series back into a single calculated molecular weight for the neutral, uncharged molecule, which is the number that should then be compared against the theoretical mass.

A spectrum showing a clean, evenly spaced series of charge states is itself a piece of supporting evidence, since it indicates a single, well-defined species is present rather than a mixture of similarly sized but distinct molecules producing an overlapping cluster of peaks.

A Matching Mass Is Strong Evidence, Not Absolute Proof

Mass spectrometry confirms molecular weight. It does not, by itself, confirm sequence, meaning it cannot always distinguish a correctly assembled peptide from a different arrangement of the same atoms that happens to weigh the same amount.

Two specific failure modes matter here. The first is isomers: two peptides built from the same set of amino acids in different quantities, or the same amino acids linked in a different order, can share an identical or near-identical molecular formula and therefore an identical mass, while being structurally distinct compounds. The second is sequence scrambling, where a synthesis error swaps the position of two residues without changing the total amino acid composition, again producing a peptide of the correct mass but the wrong actual structure.

A matching mass is real, meaningful evidence and rules out a large number of possible problems, including the wrong peptide entirely, a truncated synthesis product, or a major synthesis-related side reaction. It does not, on its own, rule out every possible internal rearrangement. That is the specific gap that additional structural methods are built to close.

When Amino Acid Analysis or Sequencing Adds What Mass Cannot

Two additional methods close the gap that mass alone leaves open.

• Amino acid analysis, abbreviated AAA, hydrolyzes the peptide into its individual free amino acids and quantifies each one, confirming the correct amino acid composition and ratio. It does not confirm sequence order, but it does independently verify that the building blocks present are the ones expected, and in the expected proportion, which catches certain substitution and composition errors that a matching mass alone would miss.
• Sequencing, commonly by tandem mass spectrometry, where the intact peptide ion is fragmented and the fragment masses are used to read out the order of residues, directly confirms sequence rather than just composition or total mass. This is the method that actually closes the isomer and scrambling gap described above.

Neither of these is standard on every commercial COA, since they add real cost and turnaround time, but for a peptide such as GHK-Cu, BPC-157, or CJC-1295, where the specific sequence and structure matters for the research use in question, a mass match alone is a reasonable baseline, not a complete structural confirmation.

Reading the Identity Line on a COA, and the Dangerous Failure Mode

A usable identity section on a COA should state, at minimum: the method used, ESI-MS or MALDI-TOF, the observed mass, the theoretical mass for the specific compound claimed, and the deviation between them. If charge states were observed and deconvoluted, that is worth stating as well, since it is additional confirmation of a clean, single species.

The failure mode worth understanding clearly, because it is the one that actually undermines a lab's confidence in its own materials, is this: a sample can show excellent HPLC purity, a tight single peak at a high percentage, while carrying the wrong identity entirely. Purity testing only evaluates homogeneity of whatever was loaded onto the column. If the wrong compound was synthesized from the start, a clean synthesis of the wrong molecule will still produce a clean, high-purity peak. Nothing about the purity number itself would ever reveal the mismatch.

This is precisely why identity and purity have to be reported and read as two separate lines, never collapsed into a single overall quality impression, and why a COA that reports only one of the two has left the more consequential question unanswered.